Insugen 30/70

Insugen 30/70

Manufacturer:

Biocon

Distributor:

Duopharma Marketing

Marketer:

Duopharma Marketing
Concise Prescribing Info
Contents
Per mL 30% soluble insulin & 70% isophane insulin (rDNA origin)
Indications/Uses
DM.
Dosage/Direction for Use
Individualized dosage. 0.3-1 IU/kg daily.
Contraindications
Hypersensitivity. Hypoglycaemia.
Special Precautions
Type 1 DM. Activity or diet changes. Transfer to another type or brand of insulin should be done under medical supervision. Inj site reactions. May affect ability to drive or operate machinery. Renal or hepatic impairment. Insulin requirement changes during pregnancy.
Adverse Reactions
Hypoglycaemia. Acute painful neuropathy. Temporary worsening of diabetic retinopathy. Lipodystrophy. Inj site reactions eg, redness, swelling, itching, pain & haematoma. Oedema. Urticaria, rash.
Drug Interactions
Deterioration in cardiac symptoms w/ pioglitazone. Oral hypoglycaemic agents, MAOIs, nonselective β-blocking agents, ACE inhibitors, salicylates, alcohol, anabolic steroids & sulphonamides may reduce insulin requirement. OCs, thiazides, glucocorticoids, thyroid hormones & β-sympathomimetics, growth hormone & danazol may increase insulin requirement. Octreotide/lanreotide may increase & decrease insulin requirement. Alcohol may intensify & prolong hypoglycaemic effect.
ATC Classification
A10AD01 - insulin (human) ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
Presentation/Packing
Form
Insugen 30/70 susp for inj (cartridge)
Packing/Price
3 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in